Wellington Biomedical Innovation Master Investors (Cayman) I L.P.'s Net Worth

$242 Million

Who is Wellington Biomedical Innovation Master Investors (Cayman) I L.P.?

Wellington Biomedical Innovation Master Investors (Cayman) I L.P. has an estimated net worth of $242 Million. This is based on reported shares across multiple companies, which include PMV Pharmaceuticals, Inc., Dyne Therapeutics, Inc., Generation Bio Co., Verve Therapeutics, Inc., Nurix Therapeutics, Inc., Edgewise Therapeutics, Inc., Nuvalent, Inc., Forma Therapeutics Holdings, Inc.,, Kymera Therapeutics, Inc., Aligos Therapeutics, Inc., Black Diamond Therapeutics, Inc., Olema Pharmaceuticals, Inc., Acrivon Therapeutics, Inc., Boundless Bio, Inc., and Artiva Biotherapeutics, Inc..

SEC CIK

Wellington Biomedical Innovation Master Investors (Cayman) I L.P.'s CIK is 0001787092

Past Insider Trading and Trends

2020 was Wellington Biomedical Innovation Master Investors (Cayman) I L.P.'s most active year for acquiring shares with 13 total transactions. Wellington Biomedical Innovation Master Investors (Cayman) I L.P.'s most active month to acquire stocks was the month of May. 2020 was Wellington Biomedical Innovation Master Investors (Cayman) I L.P.'s most active year for disposing of shares, totalling 11 transactions. Wellington Biomedical Innovation Master Investors (Cayman) I L.P.'s most active month to dispose stocks was the month of May. 2020 saw Wellington Biomedical Innovation Master Investors (Cayman) I L.P. paying a total of $40,900,000.00 for 12,677,817 shares, this is the most they've acquired in one year. In 2021 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. cashed out on 28,620,942 shares for a total of $0.00, their largest year based on trade value.